![]() ![]() He became Director of the Nicola Murray Centre for Ovarian Cancer in 2016 and Clinical Director of the Cancer Research UK Edinburgh Centre in 2019. He received a Scottish Senior Clinical Fellowship Award in 2010. Charlie was appointed Senior Lecturer in Medical Oncology at the University of Edinburgh in 2005, Reader in Medical Oncology in 2011 and Professor of Medical Oncology (Personal Chair) in 2012. From 1998 to 2005 he trained in Medical Oncology at the Edinburgh Cancer Centre, during which time he was awarded a PhD in ovarian cancer genetics (Edinburgh University) and an NHS Education for Scotland Clinician Scientist Award (2004). Professor Charlie Gourley graduated in Genetics and Medicine from Glasgow University in 19 respectively. His research spans cytotoxic, small molecule, metabolic and even psychological therapies, but his main focus is immunotherapies, where he is the clinical lead for the Edinburgh Cancer Immunology network and co-lead for the ECMC Immunotherapy Strategy Group. He also continues to work in drug development, as a medical advisor in CRUK’s Centre for Drug Development. In the clinic, he runs the Edinburgh Phase I Cancer Trials Unit and also has a specialty focus on renal cancer. ![]() After clinical training in the UK (Cambridge, Edinburgh), Australia (Melbourne) & New Zealand (Christchurch), and research in academia, clinic & industry (AstraZeneca, various UK biotechs), he is now the joint lead for the Edinburgh Experimental Cancer Medicine Centre, where he provides the link between Edinburgh’s laboratory discoveries and their clinical development. ![]() Dr Stefan Symeonides is a Medical Oncologist and Senior Clinical Lecturer in Experimental Cancer Medicine at the Cancer Research UK Edinburgh Centre (University of Edinburgh) and at the linked Edinburgh Cancer Centre (NHS Lothian). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
February 2023
Categories |